In this article, we will discuss Olaparib (Medication Guide-1). So, let’s get started.
Olaparib (Medication Guide-1)
Olaparib may cause serious side effects, including:
Bone marrow problems called Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Some people who have ovarian cancer or breast cancer and who have received previous treatment with chemotherapy, radiotherapy or certain other medicines for their cancer have developed MDS or AML during treatment with Olaparib. MDS or AML may lead to death. If you develop MDS or AML, your healthcare provider will stop treatment with Olaparib. Symptoms of low blood cell counts are common during treatment with Olaparib but can be a sign of serious bone marrow problems, including MDS or AML. Symptoms may include: • weakness • weight loss • fever • frequent infections • blood in urine or stool • shortness of breath • feeling very tired • bruising or bleeding more easily.
Your healthcare provider will do blood tests to check your blood cell counts:
• before treatment with Olaparib
• every month during treatment with Olaparib
• weekly if you have low blood cell counts that last a long time. Your healthcare provider may stop treatment with Olaparib until your blood cell counts improve.